RDY · Dr Reddys Laboratories Ltd · Fails to Deliver
$14.15
+0.40 (+2.91%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$11.73B
Shares
833.07M
Volume · Oct 28
3.41M
Avg daily vol (3M)
2.91M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-09-30 | 33 | $12.85 | $424 |
| 2026-09-29 | 91,915 | $12.51 | $1,149,857 |
| 2026-09-28 | 57,924 | $12.25 | $709,569 |
| 2026-09-25 | 66,602 | $12.30 | $819,205 |
| 2026-09-22 | 97,556 | $12.40 | $1,209,694 |
| 2026-09-21 | 933 | $12.19 | $11,373 |
| 2026-09-18 | 140,620 | $12.19 | $1,714,158 |
| 2026-09-15 | 662 | $11.91 | $7,884 |
| 2026-09-14 | 302,977 | $11.90 | $3,605,426 |
| 2026-09-11 | 80,594 | $11.71 | $943,756 |
| 2026-09-10 | 5 | $11.88 | $59 |
| 2026-09-04 | 89,397 | $12.03 | $1,075,446 |
| 2026-09-01 | 93,128 | $12.13 | $1,129,643 |
| 2026-08-31 | 51,293 | $12.18 | $624,749 |
| 2026-08-28 | 9,727 | $12.16 | $118,280 |
| 2026-08-26 | 3,497 | $12.34 | $43,153 |
| 2026-08-25 | 30 | $12.22 | $367 |
| 2026-08-19 | 70,789 | $12.15 | $860,086 |
| 2026-08-18 | 80,331 | $12.11 | $972,808 |
| 2026-08-17 | 50,284 | $12.27 | $616,985 |
| 2026-08-14 | 1 | $12.42 | $12 |
| 2026-08-12 | 5,423 | $12.45 | $67,516 |
| 2026-08-11 | 5,379 | $12.15 | $65,355 |
| 2026-08-06 | 78,285 | $12.14 | $950,380 |
| 2026-08-05 | 1,347 | $12.10 | $16,299 |
| 2026-08-03 | 31 | $11.85 | $367 |
| 2026-07-31 | 4 | $11.83 | $47 |
| 2026-07-30 | 280 | $11.76 | $3,293 |
| 2026-07-29 | 40 | $11.73 | $469 |
| 2026-07-28 | 6 | $11.77 | $71 |
Showing 1–30 of 30 settlements
Key facts
CIK
1135951
CUSIP
256135203
13F (30d)
56 filings
51 filers
Visit website
Investor relations